57894-505 : Darzalex Iv 100 mg/5ml Intravenous Injection, Solution, Concentrate
NDC: | 57894-505 |
Labeler: | Janssen Biotech, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Darzalex Iv |
Dosage Form: | Intravenous Injection, Solution, Concentrate |
Application #: | BLA761036 |
Rev. Date: |
NDC Package Codes:
- 57894-505-05: 1 VIAL, SINGLE‑DOSE IN 1 BOX (57894‑505‑05) > 5 ML IN 1 VIAL, SINGLE‑DOSE
- 57894-505-20: 1 VIAL, SINGLE‑DOSE IN 1 BOX (57894‑505‑20) > 20 ML IN 1 VIAL, SINGLE‑DOSE
Active Ingredients:
- Daratumumab
Dosage Strength:
- 100 mg/5mL
Pharmaceutical Classes:
- Antibodies
- Monoclonal [CS]
- CD38-directed Antibody Interactions [MoA]
- CD38-directed Cytolytic Antibody [EPC]
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 57894-503Next: 57894-640 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.